Characterization of the Humanized FRG Mouse Model and Development of an AAV-LK03 Variant with Improved Liver Lobular Biodistribution
Overview
Authors
Affiliations
Recent clinical successes have intensified interest in using adeno-associated virus (AAV) vectors for therapeutic gene delivery. The liver is a key clinical target, given its critical physiological functions and involvement in a wide range of genetic diseases. In the present study, we first investigated the validity of a liver xenograft mouse model repopulated with primary hepatocytes using single-nucleus RNA sequencing (sn-RNA-seq) by studying the transcriptomic profile of human hepatocytes pre- and post-engraftment. Complementary immunofluorescence analyses performed in highly engrafted animals confirmed that the human hepatocytes organize and present appropriate patterns of zone-dependent enzyme expression in this model. Next, we tested a set of rationally designed HSPG de-targeted AAV-LK03 variants for relative transduction performance in human hepatocytes. We used immunofluorescence, next-generation sequencing, and single-nucleus transcriptomics data from highly engrafted FRG mice to demonstrate that the optimally HSPG de-targeted AAV-LK03 displayed a significantly improved lobular transduction profile in this model.
Mice Engrafted with Human Liver Cells.
de Jong Y Semin Liver Dis. 2024; 44(4):405-415.
PMID: 39265638 PMC: 11620938. DOI: 10.1055/s-0044-1790601.
Drouyer M, Merjane J, Nedelkoska T, Westhaus A, Scott S, Lee S Mol Ther Nucleic Acids. 2024; 35(3):102264.
PMID: 39108635 PMC: 11301180. DOI: 10.1016/j.omtn.2024.102264.
Pekrun K, Stephens C, Gonzalez-Sandoval A, Goswami A, Zhang F, Tarantal A Mol Ther. 2024; 32(7):2064-2079.
PMID: 38715361 PMC: 11286812. DOI: 10.1016/j.ymthe.2024.05.005.
Harnessing whole human liver ex situ normothermic perfusion for preclinical AAV vector evaluation.
Cabanes-Creus M, Liao S, Navarro R, Knight M, Nazareth D, Lau N Nat Commun. 2024; 15(1):1876.
PMID: 38485924 PMC: 10940703. DOI: 10.1038/s41467-024-46194-y.
Drouyer M, Merjane J, Nazareth D, Knight M, Scott S, Liao S Mol Ther. 2024; 32(3):818-836.
PMID: 38297833 PMC: 10928139. DOI: 10.1016/j.ymthe.2024.01.024.